#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Parkinson's disease Superficial vein thrombosis Crigler-Najjar syndrome Isodicentric chromosome 15 syndrome Immune-mediated enterocolitis Gastrointestinal disorder Chronic lymphocytic leukaemia refractory Primary hyperoxaluria Behcet's syndrome Duchenne muscular dystrophy gene carrier Marginal zone lymphoma refractory Nephroblastoma Von Willebrand's disease Burkitt's lymphoma Myeloid leukaemia More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome Mucopolysaccharidosis II – Diagnostics Short-bowel syndrome Hypereosinophilic syndrome – Life with Disease Proteus syndrome Glomerulonephritis membranous – Treatment Osteosarcoma – Life with Disease Ocular melanoma – Treatment Pemphigus – Basic Information Glomerulonephritis rapidly progressive – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cat Epithelium Extract Linvoseltamab Tenofovir Disoproxil Fumarate XELAFASLATIDE H2-Receptor Antagonist Dorzolamide Hydrochloride Davutamig Azd8421 Pyridoxine Hydrochloride Bp ZUNIBERGENE ROCPARVOVEC Burfiralimab Rezafungin Acetate Baclofen HSP-CAR19M Dexamethasone Acetate Timrepigene Emparvovec Vorinostat SECRETIN SYNTHETIC HUMAN Talquetamab Carfilzomib More therapies…

    Learn about Your Condition

    Cutaneous sarcoidosis Portal hypertension Endometrial cancer metastatic Liver disorder Liposarcoma Genitourinary tract neoplasm Pelvic venous thrombosis Interstitial lung disease Yellow fever Testicular germ cell cancer Coronary artery bypass Medullary thyroid cancer Bronchostenosis Cervix carcinoma stage I Palpitations More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on ER004 for Treating Boys with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Congenital ectodermal dysplasia
    Investigated Drugs:
    • Human Immunoglobulin G1 Constant Region – Human Ectodysplasin-A1 Receptor-Binding Domain Fusion Protein
    France Germany Italy Spain

  • Study on Efavirenz for Patients with Early Alzheimer’s Disease

    Recruiting

    1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Efavirenz
    The Netherlands

  • Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Pioglitazone
    • Empagliflozin
    • Semaglutide
    Denmark Sweden

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Erdafitinib
    • Gemcitabine Hydrochloride
    • Mitomycin
    Austria Belgium Czechia Denmark France Germany +4

  • Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Capecitabine
    • Codeine Phosphate
    Austria Belgium Czechia Denmark Finland France +9

  • Study on Fluid Management to Reduce Post-Surgery Complications in Brain Surgery Patients Using Magnesium Chloride, Potassium Chloride, and Sodium Chloride

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    • Sodium Acetate Trihydrate
    Czechia
Previous Page
1 … 501 502 503 504 505 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!